CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives

Patients with epithelial ovarian cancer (EOC) are often diagnosed at an advanced stage due to nonspecific symptoms and ineffective screening approaches. Although chemotherapy has been available and widely used for the treatment of advanced EOC, the overall prognosis remains dismal. As part of the in...

Full description

Bibliographic Details
Main Authors:	Xinxin Huang, Juncheng Hao, Yan Qin Tan, Tao Zhu, Vijay Pandey, Peter E. Lobie
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	International Journal of Molecular Sciences
Subjects:	ovarian cancer CXC chemokine ligand (CXCL) CXC chemokine receptor (CXCR) tumor microenvironment (TME)
Online Access:	https://www.mdpi.com/1422-0067/23/5/2642

Similar Items

The Role of CXC Chemokines in Cancer Progression
by: Tiantian Wu, et al.
Published: (2022-12-01)

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
by: Xiaoqi Sun, et al.
Published: (2021-07-01)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
by: Yanhua Jing, et al.
Published: (2022-04-01)

CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions
by: Mohammad Hassan Mohammadi, et al.
Published: (2021-06-01)

The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses
by: Mojgan Noroozi Karimabad, et al.
Published: (2022-08-01)

The CXC Chemokine Receptors in Four-Eyed Sleeper (<i>Bostrychus sinensis</i>) and Their Involvement in Responding to Skin Injury
by: Mengdan Dong, et al.
Published: (2021-09-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
by: Jan Korbecki, et al.
Published: (2021-01-01)

ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
by: Boshagh MA, et al.
Published: (2019-06-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
by: Joanna Motyka, et al.
Published: (2023-06-01)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
by: Weina Kong, et al.
Published: (2021-07-01)

Sequence characterization and expression pattern analysis of chemokines CXCL13 and CXCL14 in Asian swamp eel
by: Dingda Xu, et al.
Published: (2020-11-01)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
by: Alireza Nazari, et al.
Published: (2020-03-01)

The Role of CXC Chemokines in Cardiovascular Diseases
by: Xiyi Lu, et al.
Published: (2022-05-01)

PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2005-03-01)

Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice
by: Michael Guo, et al.
Published: (2018-04-01)

Evolutionarily conserved mechanisms regulating stress-induced neutrophil redistribution in fish
by: Katarzyna Klak, et al.
Published: (2024-03-01)

Association of Gene Polymorphisms in CXC Chemokine Receptor 5 with Rheumatoid Arthritis Susceptibility
by: Zhenzhen Su, et al.
Published: (2022-10-01)

CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
by: Naoya Nagaya, et al.
Published: (2020-10-01)

Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis
by: Caiyun Wu, et al.
Published: (2021-09-01)

CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
by: Caitlin Molczyk, et al.
Published: (2023-02-01)

Molecular Identification and Dual Functions of Two Different CXC Chemokines in Nile Tilapia (<i>Oreochromis niloticus</i>) against <i>Streptococcus agalactiae</i> and <i>Flavobacterium columnare</i>
by: Chatsirin Nakharuthai, et al.
Published: (2020-07-01)

Targeting G protein-coupled receptor for pain management
by: Hongyan Li, et al.
Published: (2017-01-01)

CXC chemokine ligand 12α-mediated increase in insulin secretion and survival of mouse pancreatic islets in response to oxidative stress through modulation of calcium uptake
by: Vidaković Melita, et al.
Published: (2018-01-01)

Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus
by: Amin Ullah, et al.
Published: (2023-10-01)

CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis
by: Lu Wang, et al.
Published: (2020-02-01)

Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer
by: Sven H. Loosen, et al.
Published: (2022-08-01)

Correlation between the expressions of CXCL8 and miR-150 in the skin lesions and the severity of psoriasis vulgaris
by: MA Hui, BI Xiaodong
Published: (2023-02-01)

A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01)

Silenced CXCL12 inhibits ox-LDL-induced foaming and apoptosis in mouse macrophage cell line RAW264.7
by: ZHUANG Hong, ZHANG Su-chuan, LIU Hui-di, XU Ya-ning, HUANG Lu, DAI Tian, JIANG Pin
Published: (2021-02-01)

Chemotactic Cues for NOTCH1-Dependent Leukemia
by: Erich Piovan, et al.
Published: (2018-04-01)

CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway
by: Jia-Hui Gao, et al.
Published: (2019-12-01)

Effects of SDF-1/CXCR7 on the Migration, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells
by: Ameng Shi, et al.
Published: (2021-11-01)

Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
by: Lian-Tao Hu, et al.
Published: (2022-06-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)

CXCR3 chemokine receptor ligands in sarcoidosis
by: N. M. Lazareva, et al.
Published: (2021-03-01)

CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1
by: Zhao D, et al.
Published: (2019-12-01)

Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy—An Integrated View into Other Neoplasms and Chemokine Networks
by: Anca Filimon, et al.
Published: (2021-12-01)

Characterization and distribution of HIV-infected cells in semen
by: Lin Gao, et al.
Published: (2022-12-01)